Abstract
This study analyzed the prevalence and antibiotic susceptibility of urogenital Ureaplasma urealyticum and Mycoplasma hominis isolated in Xi’an, China. A total of 2161 individuals from 2011 to 2015 were included, and antibiotic susceptibility tests were performed by using the Mycoplasma IST kit. Of the individuals studied, 1018 (47.11 %) were identified to be positive for urogenital mycoplasmas. The single U. urealyticum, single M. hominis, and dual U. urealyticum and M. hominis infections accounted for 772 (75.83 %), 66 (6.48 %), and 180 (17.68 %), respectively. The total positive rate was higher in females than in males (58.76 % vs. 28.86 %, p < 0.001). The highest total positive rate (48.88 %) was observed in individuals aged 25 years to 30 years. In symptomatic and asymptomatic individuals, the positive rates were both higher in females than in males (67.36 % vs. 31.02 %, p < 0.001 and 42.58 % vs. 7.69 %, p < 0.001, respectively) and individuals aged 25 years to 30 years, and those aged 30 years to 35 years had the highest positive rates (54.35 and 57.14 %, respectively). The U. urealyticum and M. hominis identified from single or dual infections displayed low resistance rates to josamycin, doxycycline, and minocycline (<10 %) in both the symptomatic and asymptomatic groups. These results suggest that females and individuals with symptoms and younger age had higher mycoplasma infection rates and that josamycin, doxycycline, and minocycline may be recommended for the clinical treatment of patients infected with urogenital mycoplasmas, irrespective of the symptoms.
Similar content being viewed by others
References
Leli C, Mencacci A, Bombaci JC, D’Alò F, Farinelli S, Vitali M, Montagna P, Bietolini C, Meucci M, Perito S, Bistoni F (2012) Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients. Infez Med 20(2):82–87
Zhang N, Wang R, Li X, Liu X, Tang Z, Liu Y (2014) Are Ureaplasma spp. a cause of nongonococcal urethritis? A systematic review and meta-analysis. PLoS One 9(12):e113771. doi:10.1371/journal.pone.0113771
Tibaldi C, Cappello N, Latino MA, Masuelli G, Marini S, Benedetto C (2009) Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect 15(7):670–679. doi:10.1111/j.1469-0691.2009.02842.x
Azizmohammadi S, Azizmohammadi S (2015) Antimicrobial susceptibility patterns of Ureaplasma urealyticum and Mycoplasma hominis isolated from pregnant women. Iran Red Crescent Med J 17(12):e17211. doi:10.5812/ircmj.17211
Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, Pablos-Mendez A, Klugman KP (2005) Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 5(8):481–493. doi:10.1016/S1473-3099(05)70189-4
Skiljevic D, Mirkov D, Vukicevic J (2016) Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital. Indian J Dermatol Venereol Leprol 82(1):37–41. doi:10.4103/0378-6323.172903
Salado-Rasmussen K, Jensen JS (2014) Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis 59(1):24–30. doi:10.1093/cid/ciu217
Song T, Ye A, Xie X, Huang J, Ruan Z, Kong Y, Song J, Wang Y, Chen J, Zhang J (2014) Epidemiological investigation and antimicrobial susceptibility analysis of Ureaplasma species and Mycoplasma hominis in outpatients with genital manifestations. J Clin Pathol 67(9):817–20. doi:10.1136/jclinpath-2014-202248
Kouegnigan Rerambiah L, Ndong JC, Medzegue S, Elisee-Ndam M, Djoba Siawaya JF (2015) Genital Mycoplasma infections and their resistance phenotypes in an African setting. Eur J Clin Microbiol 34(6):1087–1090. doi:10.1007/s10096-015-2326-9
Pónyai K, Mihalik N, Ostorházi E, Farkas B, Párducz L, Marschalkó M, Kárpáti S, Rozgonyi F (2013) Incidence and antibiotic susceptibility of genital Mycoplasmas in sexually active individuals in Hungary. Eur J Clin Microbiol Infect Dis 32(11):1423–1426. doi:10.1007/s10096-013-1892-y
Ye G, Jiang Z, Wang M, Huang J, Jin G, Lu S (2014) The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens. Cell Biochem Biophys 68(1):207–210. doi:10.1007/s12013-013-9691-8
De Francesco MA, Caracciolo S, Bonfanti C, Manca N (2013) Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother 19(4):621–627. doi:10.1007/s10156-012-0527-z
Bayraktar MR, Ozerol IH, Gucluer N, Celik O (2010) Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis 14(2):e90–e95. doi:10.1016/j.ijid.2009.03.020
Wang QY, Li RH, Zheng LQ, Shang XH (2014) Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009–2013. J Microbiol Immunol Infect 49(3):359–362. doi:10.1016/j.jmii.2014.06.007
Samra Z, Rosenberg S, Dan M (2011) Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother 23(2):77–79. doi:10.1179/joc.2011.23.2.77
Zhu C, Liu J, Ling Y, Dong C, Wu T, Yu X, Hou Y, Dong L, Cheng X (2012) Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Chinese women with genital infectious diseases. Indian J Dermatol Venereol Leprol 78(3):406–407. doi:10.4103/0378-6323.95480
Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, Pablos-Mendez A, Laxminarayan R (2005) Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis 5(9):568–580. doi:10.1016/S1473-3099(05)70217-6
Acknowledgments
The project was sponsored by the National Natural Science Foundation of China (no. 81201326).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics statements
This study was initiated after receiving approval from the Institutional Review Board of the First Affiliated Hospital of Xi’an Jiaotong University and carried out according to the Helsinki Declaration. Informed consent was obtained from all the participants.
Rights and permissions
About this article
Cite this article
Zeng, XY., Xin, N., Tong, XN. et al. Prevalence and antibiotic susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Xi’an, China. Eur J Clin Microbiol Infect Dis 35, 1941–1947 (2016). https://doi.org/10.1007/s10096-016-2745-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2745-2